Journal Title:European Stroke Journal
The European Stroke Journal (ESJ), as the official journal of the European Stroke Organisation (ESO), plays a pivotal role in disseminating the latest scientific discoveries and clinical advancements in the field of stroke medicine. The peer-review process of the journal ensures the rigor and high quality of the published content, providing an invaluable resource for healthcare professionals worldwide.ESJ places special emphasis on the entire process of stroke management, from prevention, diagnosis, treatment, to rehabilitation, offering a comprehensive perspective for clinicians and researchers. It highlights the importance of interdisciplinary collaboration, encouraging experts from various fields such as neurology, cardiovascular medicine, rehabilitation science, and public health to share their knowledge and experience.Furthermore, ESJ also focuses on the translational aspects of stroke research, such as applying the findings of basic scientific research to improve patient outcomes and quality of life. This includes innovative treatment methods, the application of emerging technologies, and the updating and evaluation of existing clinical guidelines.
By publishing research on the organization of stroke care and its societal impact, ESJ also emphasizes the impact of stroke on patients, families, and society as a whole, promoting a broader understanding of the burden of stroke disease. These studies help guide policy-making, optimize resource allocation, and raise public awareness of stroke prevention and treatment.The publication of ESJ not only facilitates academic exchange in the field of stroke medicine but also supports the improvement of clinical practice and the quality of patient care, making a significant contribution to global stroke prevention and treatment efforts.
《歐洲卒中雜志》(ESJ)作為歐洲卒中組織(ESO)的官方期刊,扮演著傳播卒中醫(yī)學領(lǐng)域最新科學發(fā)現(xiàn)和臨床進展的關(guān)鍵角色。該期刊的同行評審過程確保了發(fā)表內(nèi)容的嚴謹性和高質(zhì)量,為全球醫(yī)療專業(yè)人員提供了一個寶貴的資源。ESJ特別注重卒中管理的全流程,從預防、診斷到治療以及康復,為臨床醫(yī)生和研究人員提供了全面的視角。它強調(diào)了跨學科合作的重要性,鼓勵來自神經(jīng)學、心血管醫(yī)學、康復科學和公共衛(wèi)生等不同領(lǐng)域的專家分享他們的知識和經(jīng)驗。此外,ESJ還關(guān)注卒中研究的轉(zhuǎn)化方面,如將基礎(chǔ)科學研究的發(fā)現(xiàn)應用于改善患者的治療效果和生活質(zhì)量。這包括創(chuàng)新的治療方法、新興技術(shù)的應用以及對現(xiàn)有臨床指南的更新和評估。
通過發(fā)表關(guān)于卒中護理組織和社會影響的研究,ESJ也強調(diào)了卒中對患者、家庭以及整個社會的影響,促進了對卒中疾病負擔更廣泛的認識和理解。這些研究有助于指導政策制定,優(yōu)化資源分配,并提高公眾對卒中預防和治療的認識。ESJ的出版,不僅促進了卒中醫(yī)學領(lǐng)域的學術(shù)交流,也支持了臨床實踐的改進和患者護理質(zhì)量的提升,對全球卒中防治工作做出了重要貢獻。
European Stroke Journal由SAGE出版商出版,收稿方向涵蓋Multiple全領(lǐng)域,此刊是中等級別的SCI期刊,所以過審相對來講不是特別難,但是該刊專業(yè)認可度不錯,仍然是一本值得選擇的SCI期刊 。平均審稿速度 ,影響因子指數(shù)5.8,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
大類學科 | 分區(qū) | 小類學科 | 分區(qū) | Top期刊 | 綜述期刊 |
醫(yī)學 | 3區(qū) | CLINICAL NEUROLOGY 臨床神經(jīng)病學 PERIPHERAL VASCULAR DISEASE 外周血管病 | 3區(qū) 3區(qū) | 否 | 否 |
名詞解釋:
中科院分區(qū)也叫中科院JCR分區(qū),基礎(chǔ)版分為13個大類學科,然后按照各類期刊影響因子分別將每個類別分為四個區(qū),影響因子5%為1區(qū),6%-20%為2區(qū),21%-50%為3區(qū),其余為4區(qū)。
大類學科 | 分區(qū) | 小類學科 | 分區(qū) | Top期刊 | 綜述期刊 |
醫(yī)學 | 3區(qū) | CLINICAL NEUROLOGY 臨床神經(jīng)病學 PERIPHERAL VASCULAR DISEASE 外周血管病 | 3區(qū) 3區(qū) | 否 | 否 |
按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:CLINICAL NEUROLOGY | SCIE | Q1 | 25 / 277 |
91.2% |
學科:PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | 9 / 96 |
91.1% |
按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
學科:CLINICAL NEUROLOGY | SCIE | Q1 | 34 / 278 |
87.95% |
學科:PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | 12 / 96 |
88.02% |
名詞解釋:
WOS即Web of Science,是全球獲取學術(shù)信息的重要數(shù)據(jù)庫,Web of Science包括自然科學、社會科學、藝術(shù)與人文領(lǐng)域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術(shù)會議多學科內(nèi)容。給期刊分區(qū)時會按照某一個學科領(lǐng)域劃分,根據(jù)這一學科所有按照影響因子數(shù)值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區(qū)中,最后的劃分結(jié)果分別是Q1,Q2,Q3,Q4,Q1代表質(zhì)量最高。
CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
7.5 | 2.201 | 2.319 |
|
名詞解釋:
CiteScore:衡量期刊所發(fā)表文獻的平均受引用次數(shù)。
SJR:SCImago 期刊等級衡量經(jīng)過加權(quán)后的期刊受引用次數(shù)。引用次數(shù)的加權(quán)值由施引期刊的學科領(lǐng)域和聲望 (SJR) 決定。
SNIP:每篇文章中來源出版物的標準化影響將實際受引用情況對照期刊所屬學科領(lǐng)域中預期的受引用情況進行衡量。
是否OA開放訪問: | h-index: | 年文章數(shù): |
未開放 | -- | 113 |
Gold OA文章占比: | 2021-2022最新影響因子(數(shù)據(jù)來源于搜索引擎): | 開源占比(OA被引用占比): |
36.02% | 5.8 | 0.29... |
研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
90.27% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發(fā)文量:
歷年中科院JCR大類分區(qū)數(shù)據(jù):
歷年自引數(shù)據(jù):
2023-2024國家/地區(qū)發(fā)文量統(tǒng)計:
國家/地區(qū) | 數(shù)量 |
England | 53 |
Netherlands | 41 |
Scotland | 35 |
GERMANY (FED REP GER) | 34 |
Italy | 30 |
Switzerland | 27 |
Sweden | 26 |
USA | 25 |
France | 23 |
Spain | 21 |
2023-2024機構(gòu)發(fā)文量統(tǒng)計:
機構(gòu) | 數(shù)量 |
UNIVERSITY OF GLASGOW | 22 |
UNIVERSITY OF EDINBURGH | 19 |
UNIVERSITY OF LONDON | 19 |
UTRECHT UNIVERSITY | 19 |
UNIVERSITY OF OSLO | 17 |
UNIVERSITY OF AMSTERDAM | 16 |
UNIVERSITY OF BERN | 16 |
LUND UNIVERSITY | 15 |
UNIVERSITY OF OXFORD | 15 |
UNIVERSITY OF PERUGIA | 14 |
同小類學科的其他優(yōu)質(zhì)期刊 | 影響因子 | 中科院分區(qū) |
Toxicon | 2.6 | 4區(qū) |
Journal Of Knee Surgery | 1.6 | 4區(qū) |
International Journal Of Sports Medicine | 2 | 4區(qū) |
Journal Of Ethnopharmacology | 4.8 | 2區(qū) |
Stem Cells International | 3.8 | 3區(qū) |
Journal Of Ethnobiology And Ethnomedicine | 2.9 | 2區(qū) |
Transplant Immunology | 1.6 | 4區(qū) |
Nature Reviews Endocrinology | 31 | 1區(qū) |
Medicine | 1.3 | 4區(qū) |
Asian Journal Of Surgery | 3.5 | 3區(qū) |
若用戶需要出版服務(wù),請聯(lián)系出版商。